Francesco Galimi
Direttore Tecnico/Scientifico/R&S presso ADICET BIO, INC.
Patrimonio netto: 184 260 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Francesco Galimi
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
85
| Public Company | Pharmaceuticals: Major | 85 |
Public Company | Pharmaceuticals: Major | 22 | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.
14
| Subsidiary | Pharmaceuticals: Major | 14 |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Francesco Galimi tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Masters Business Admin Undergraduate Degree | |
KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Founder Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact Director/Board Member President | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Human Resources Officer Public Communications Contact Corporate Officer/Principal | |
UCLA Anderson School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal President | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
KEZAR LIFE SCIENCES, INC. | Biotechnology | Director/Board Member Founder Chief Operating Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Director of Finance/CFO | |
University of Michigan | College/University | Doctorate Degree Masters Business Admin Corporate Officer/Principal | |
KITE PHARMA INC | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO | |
ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Chief Operating Officer | |
BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
University of Notre Dame | College/University | Undergraduate Degree Masters Business Admin | |
AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
The Business Council
The Business Council Miscellaneous Commercial ServicesCommercial Services The Business Council operates as an organization of business leaders. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Tufts University | College/University | Corporate Officer/Principal Undergraduate Degree | |
ALLERGAN, INC. | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal | |
Alliance for Cancer Gene Therapy, Inc.
Alliance for Cancer Gene Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Alliance for Cancer Gene Therapy, Inc. provides funding for cancer research. The non-profit company is based in Stamford, CT. The company was founded by Edward Netter. Kevin Honeycutt has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
JUNO THERAPEUTICS INC | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Director/Board Member | |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Executive Officer President | |
BB BIOTECH AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Human Resources Officer | |
University of Saskatchewan | College/University | Undergraduate Degree Undergraduate Degree | |
Kelley School of Business | College/University | Masters Business Admin Masters Business Admin | |
GE AEROSPACE | Industrial Machinery | General Counsel Corporate Officer/Principal | |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Consultant / Advisor Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Stati Uniti | 46 |
Svizzera | 3 |
Canada | 3 |
Regno Unito | 2 |
Settori
Health Technology | 27 |
Consumer Services | 15 |
Commercial Services | 7 |
Finance | 4 |
Producer Manufacturing | 2 |
Posizioni
Director/Board Member | 436 |
Corporate Officer/Principal | 274 |
Independent Dir/Board Member | 133 |
Undergraduate Degree | 91 |
Chief Tech/Sci/R&D Officer | 78 |
Contatti più connessi
Insiders | |
---|---|
Carl Gordon | 59 |
Frank J. Biondi | 36 |
Ellen Kullman | 34 |
Asish Xavier | 33 |
Erez Chimovits | 30 |
Fred Hassan | 29 |
David Baltimore | 27 |
Steve Dubin | 25 |
François de Carbonnel | 24 |
Michael Kauffman | 24 |
Chen Schor | 23 |
Diana McKenzie | 21 |
Wanda Austin | 20 |
Donald Santel | 20 |
Brian Kotzin | 20 |
- Borsa valori
- Insiders
- Francesco Galimi
- Connessioni Società